Consistent with our findings, Martínez-Sáez et al. previously reported a PIK3CA mutation rate of 35.7% in their breast cancer cohort, with H1047R (35%), E545K (17%), E542K (11%), N345K (6%), and H1047L (4%) as the most common mutation sites 25. Here, PIK3CA is linked to breast cancer.